Abstract
AbstractEngineering human tissue microenvironments that recapitulate the composition and biomechanics of extracellular matrix (ECM) in vitro is challenging. New mechanically tunable alginate‐based hydrogels are presented, enabling to precise model multiple ECM features in the context of breast cancer. Combining alginate, oxidized alginate (OA), and gelatin with different crosslinking strategies a library of mechanically controlled hydrogels supporting human cell growth (MDA‐MB‐231) is obtained. The compressive moduli and stability of alginate‐based hydrogels are characterized and modeled using a response surface methodology (RSM); this enables to selection of precision‐hydrogels decoupling their biochemical composition with mechanical properties (1–30 kPa). Specific alginate‐based hydrogels are selected as enhanced technologies to model breast‐specific microenvironments in vitro to study the impact of biomechanical and biochemical properties on cell behavior. Doxorubicin is selected as a model drug and as first‐line treatment for breast cancer to investigate the correlation between drug efficacy and breast tumor ECM stiffness. Results demonstrate that doxorubicin is less effective (EC50 0.495 µm vs EC50 0.189 µm) in cells cultured in softer hydrogels (6.9 kPa) than in stiffer (21.0 kPa). In the context of breast cancer, engineered hydrogels prove valuable technologies to model tissue‐specific ECM in vitro for biological studies, advancing understanding of therapeutic response and resistance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Similar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.